Charleston Neuroscience Institute

Charleston, South Carolina 29414-5896

2 studies enrolling now · 3 studies all time

What they study most

Diabetic Retinopathy, NAION( Non-arteritic Anterior Ischemic Optic Neuropathy), Neovascular Age-related Macular Degeneration, Open Angle Glaucoma (OAG), nAMD

Studies at this site

• A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration — Recruiting now
• Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR) — Completed